Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Harvard Scientific (HVSF)Hot$$- male impotency medicine -- Ignore unavailable to you. Want to Upgrade?

To: per strandberg who wrote (3616)	6/8/1998 6:48:00 AM
From: F. Jay Abella, III	Read Replies (2) \| Respond to of 3906

Nanda: The news release this time was for 12 month stability of their lead product. You think you saw this three months ago because that was the announcement of the nine month data. Stability is very important for this product, the longer it is stable in its proposed form for manufacture, the better HVSF's potential competitive advantage. FJA PS - I hope I am never perceived to be hyping this company. They wish to present themselves to our conference audience, and I am happy to have them aboard. Notably, about 1/4 of all biotechs even get an invite to our show....I think managememt has LOTS of hurdles to overcome, mostly caused by previous management. I figure, why not start a relationship with these guys, they may just pull off a great turnaround. Their incentives are aligned with success and they seem to work hard enough. Dedication is meaningful to me, and they certainly have that..... Off topic - Laurens, I remember you from the PRCY board. You are correct, John Westergaard and Mike Hardesty wrote extensively about CHAI in the past. I never did because I didn't think the firm met my criteria for risk management. Even though I am the biotech analyst, my name never appeared on the reports. This was done deliberately. Moral of the story, if I don't like something, I will either avoid it or state my opinion clearly. This is delineated nicely in our disclaimer at WBN.